Patents by Inventor David Mann

David Mann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140147556
    Abstract: The present technology provides, in one aspect, an edible or inhalable composition including an isolated “antagonist ligand” or an isolated “antagonist antibody” or an antigen-binding fragment thereof, which specifically binds a taste receptor ligand or an olfactory receptor ligand. Foods and intranasal formulations containing the above-described compositions are described, as are methods of use.
    Type: Application
    Filed: November 27, 2012
    Publication date: May 29, 2014
    Applicant: Elwha LLC
    Inventors: Maxime J. J. Bilet, Ilya Fushman, Roderick A. Hyde, Jordin T. Kare, Vinod Khosla, David Mann, Nathan P. Myhrvold, Clarence T. Tegreene, Lowell L. Wood, JR., Christopher C. Young
  • Patent number: 8609706
    Abstract: The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Grant
    Filed: May 15, 2012
    Date of Patent: December 17, 2013
    Assignee: Infinity Discovery, Inc.
    Inventors: Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward B. Holson, Brian T. Hopkins, Gregg F. Keaney, Nii O. Koney, Tao Liu, David A. Mann, Marta Nevalainen, Stephane Peluso, Lawrence Blas Perez, Daniel A. Snyder, Thomas T. Tibbitts
  • Publication number: 20130131063
    Abstract: The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Application
    Filed: May 15, 2012
    Publication date: May 23, 2013
    Applicant: Infinity Pharmaceuticals, Inc.
    Inventors: Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward B. Holson, Brian T. Hopkins, Gregg F. Keaney, Nii O. Koney, Tao Liu, David A. Mann, Marta Nevalainen, Stephane Peluso, Lawrence Blas Perez, Daniel A. Snyder, Thomas T. Tibbitts
  • Patent number: 8389119
    Abstract: A thermal interface material includes a mechanically compliant vertically aligned nanofiber film and a binder material for joining the nanofibers of the film to the surfaces of two substrates. Preferably, the binder material comprises a non-hydrocarbon-based material such as a metallic eutectic with a melting temperature below a nanofiber thermal damage threshold temperature of the film. The film is grown on a substrate which is then bonded to another substrate by the binder material in an adhesion process that may include pressure and heat. Alternatively, the film may be released from the substrate to produce a stand-alone thermal tape which may later be placed between two substrates and bonded.
    Type: Grant
    Filed: July 26, 2007
    Date of Patent: March 5, 2013
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Matthew Panzer, Kenneth E. Goodson, Xuejiao Hu, David Mann
  • Patent number: 8338686
    Abstract: An apparatus for enhancing audio comprising a first interface and a harmonizing module is disclosed. The first interface receive a first audio segment from a first source. The harmonizing module is coupled to the first interface. The harmonizing module is configured to identify at least one musical property of the first audio segment; calculate a subset of notes that are harmonious with the first audio segment based on the at least one musical property; and select from the subset of notes to generate an audio track to be played substantially synchronously with the first audio segment. A second interface may also be provided to receive a second audio segment from a second source. In this case, the harmonizing module may be configured to generate the audio track by transforming one or more notes of the second audio segment. A method is also provided.
    Type: Grant
    Filed: June 1, 2010
    Date of Patent: December 25, 2012
    Assignee: Music Mastermind, Inc.
    Inventors: David Mann, Francesco Gerald Capodieci, Reza Rassool
  • Patent number: 8252405
    Abstract: The present invention provides single-walled carbon nanotubes and systems and methods for their preparation.
    Type: Grant
    Filed: October 26, 2006
    Date of Patent: August 28, 2012
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Hongjie Dai, David Mann, Guangyu Zhang
  • Patent number: 8178690
    Abstract: The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Grant
    Filed: April 19, 2011
    Date of Patent: May 15, 2012
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward B. Holson, Brian T. Hopkins, Gregg F. Keaney, Nii O. Koney, Tao Liu, David A. Mann, Marta Nevalainen, Stephane Peluso, Lawrence Blas Perez, Daniel A. Snyder, Thomas T. Tibbitts
  • Publication number: 20110213145
    Abstract: The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Application
    Filed: April 19, 2011
    Publication date: September 1, 2011
    Applicant: Infinity Discovery, Inc.
    Inventors: Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward B. Holson, Brian T. Hopkins, Gregg F. Keaney, Nii O. Koney, Tao Liu, David A. Mann, Marta Nevalainen, Stephane Peluso, Lawrence B. Perez, Daniel A. Snyder, Thomas T. Tibbitts
  • Patent number: 7936688
    Abstract: A cross-port analysis method is provided to analyze multichannel traces in a network. More particularly, cross-port analysis is a method allowing for aggregate network analysis capabilities from a multi-channel analyzer. This can be performed as traces of network traffic generated by each port on two or more analyzers. Precise timestamps are recorded for each trace and the topology of devices on the network is determined. An expert analysis is then performed on the captured data traces.
    Type: Grant
    Filed: September 22, 2004
    Date of Patent: May 3, 2011
    Assignee: JDS Uniphase Corporation
    Inventors: Steven Ronald Klotz, Jason David Mann, Timothy Lane McDaniel
  • Patent number: 7928244
    Abstract: The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Grant
    Filed: August 21, 2007
    Date of Patent: April 19, 2011
    Assignee: Infinity Discovery, Inc.
    Inventors: Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward B. Holson, Brian T. Hopkins, Gregg F. Keaney, Nii O. Koney, Tao Liu, David A. Mann, Marta Nevalainen, Stephane Peluso, Lawrence B. Perez, Daniel A. Snyder, Thomas T. Tibbitts
  • Patent number: 7860965
    Abstract: A network monitoring architecture and methodology enabling performance detection and diagnostics in storage area networks or other networks. The network monitoring is performed using a three-tiered distributed computing system architecture, including a data source tier, a portal tier and a client tier. The data source tier monitors the physical data on the network medium using multiple data collection sources, or data probes, connected to the network. The probes analyze network data and generate metrics that describe attributes of the network data. The metrics are synchronized in time by virtue of time stamps associated with the data monitored by the data probes. The time-synchronized metrics are used by the data portal tier, which is the second tier of the system. The portal tier encapsulates the metrics into data containers. The data containers may be requested by the client tier, which is the third tier in the network monitoring system.
    Type: Grant
    Filed: April 25, 2003
    Date of Patent: December 28, 2010
    Assignee: JDS Uniphase Corporation
    Inventors: Lawrence Michael Bain, Kenneth R. Hornyak, Steven Ronald Klotz, Jason David Mann, Henry David Poelstra, Robert Witherow Otis
  • Patent number: 7851637
    Abstract: One aspect of the present invention relates to heterocyclic compounds that bind to bcl proteins and inhibit Bcl function. Another aspect of the present invention relates to compositions comprising a heterocyclic compound of the invention. The present invention provides methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Grant
    Filed: June 17, 2005
    Date of Patent: December 14, 2010
    Assignee: Infinity Pharmaceuticals, Inc.
    Inventors: Alfredo C. Castro, Wei Deng, Kristopher M. Depew, Michael A. Foley, Christian C. Fritz, Asimina T. Georges Evangelinos, Michael J. Grogan, Nafeeza Hafeez, Edward B. Holson, Brian T. Hopkins, Nii O. Koney, Tao Liu, David A. Mann, Lisa A. Marcaurelle, Daniel A. Snyder, Dennis J. Underwood, Andrew A. Wylie, Lin-Chen Yu, Linping Zhang
  • Publication number: 20100307321
    Abstract: An apparatus for enhancing audio comprising a first interface and a harmonizing module is disclosed. The first interface receive a first audio segment from a first source. The harmonizing module is coupled to the first interface. The harmonizing module is configured to identify at least one musical property of the first audio segment; calculate a subset of notes that are harmonious with the first audio segment based on the at least one musical property; and select from the subset of notes to generate an audio track to be played substantially synchronously with the first audio segment. A second interface may also be provided to receive a second audio segment from a second source. In this case, the harmonizing module may be configured to generate the audio track by transforming one or more notes of the second audio segment. A method is also provided.
    Type: Application
    Filed: June 1, 2010
    Publication date: December 9, 2010
    Applicant: Music Mastermind, LLC
    Inventors: David Mann, Francesco Gerald Capodieci, Reza Rassool
  • Patent number: 7848487
    Abstract: Methods are disclosed for sterilizing biological materials to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, chlamydia, rickettsias), yeasts, molds, fungi, prions or similar agents responsible, alone or in combination, for TSEs and/or single or multicellular parasites. The methods involve sterilizing biological materials containing one or more non-aqueous solvents with irradiation.
    Type: Grant
    Filed: November 3, 2008
    Date of Patent: December 7, 2010
    Assignee: Clearant, Inc.
    Inventors: Shirley Miekka, Martin J. Macphee, William N. Drohan, David Mann, Wilson Burgess
  • Publication number: 20100098904
    Abstract: The present invention provides single-walled carbon nanotubes and systems and methods for their preparation.
    Type: Application
    Filed: October 26, 2006
    Publication date: April 22, 2010
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Hongjie Dai, David Mann, Guangyu Zhang
  • Publication number: 20100003728
    Abstract: Provided are deglycosylation methods designed to optimize the yield of Veratrum alkaloid from Veratrum plant material and/or from an extract of Veratrum plant material.
    Type: Application
    Filed: July 1, 2009
    Publication date: January 7, 2010
    Inventors: Gamini Senerath Jayatilake, Steven L. Richheimer, David A. Mann
  • Publication number: 20090214382
    Abstract: Methods are disclosed for sterilizing biological materials to reduce the level of one or more biological contaminants or pathogens therein, such as viruses, bacterial (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, chlamydia, rickettsias), yeasts, molds, fungi, single or multicellular parasites, and/or prions or similar agents responsible. These methods involve the use of alpha-keto acids in methods of sterilizing biological materials with irradiation.
    Type: Application
    Filed: May 5, 2005
    Publication date: August 27, 2009
    Inventors: Wilson Burgess, David Mann, William Drohan, Shirley Miekka
  • Publication number: 20090202039
    Abstract: Methods are disclosed for sterilizing biological materials to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, chlamydia, rickettsias), yeasts, molds, fungi, prions or similar agents responsible, alone or in combination, for TSEs and/or single or multicellular parasites. The methods involve sterilizing biological materials containing one or more non-aqueous solvents with irradiation.
    Type: Application
    Filed: November 3, 2008
    Publication date: August 13, 2009
    Inventors: Shirley Miekka, Martin J. Macphee, William N. Drohan, David Mann, Wilson Burgess
  • Publication number: 20090078214
    Abstract: Pet toys configured to accept an edible or chewable treat which can be readily replaced. The pet toys have a first portion and a second portion which releaseably engage to retain the edible treat with the toy until the treat is consumed or otherwise removed from the toy by the pet. When desired, the toy can be disassembled by removing the first portion from the second portion, new treats can be added to the toy, and the two portions reassembled.
    Type: Application
    Filed: September 20, 2007
    Publication date: March 26, 2009
    Inventor: Charles David Mann
  • Publication number: 20090068387
    Abstract: A thermal interface material includes a mechanically compliant vertically aligned nanofiber film and a binder material for joining the nanofibers of the film to the surfaces of two substrates. Preferably, the binder material comprises a non-hydrocarbon-based material such as a metallic eutectic with a melting temperature below a nanofiber thermal damage threshold temperature of the film. The film is grown on a substrate which is then bonded to another substrate by the binder material in an adhesion process that may include pressure and heat. Alternatively, the film may be released from the substrate to produce a stand-alone thermal tape which may later be placed between two substrates and bonded.
    Type: Application
    Filed: July 26, 2007
    Publication date: March 12, 2009
    Inventors: Matthew Panzer, Kenneth E. Goodson, Xuejiao Hu, David Mann